3,729 items to be re-evaluated over economic effectiveness

Published: 2008-09-05 07:00:00

Updated: 2008-09-05 07:00:00

The Health Insurance Review and Assess Service (HIRA) announced on September 2 that a total of 3,729 items from six therapeutic categories will be evaluated for their economic effectiveness within this year.

The six therapeutic categories include antihypertensives, miscellaneous drugs acting o...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK